Target Discovery
Ready-to-use AI-driven applications to discover and evaluate predicted novel targets to improve preclinical pipeline performance
Novel targets to drive the preclinical pipeline
We work closely with many pharmaceutical & biotech companies to accelerate and de-risk their Target discovery process. Euretos' computational, AI-driven disease models predict novel target associations that domain experts can evaluate rapidly using our AI-integrated knowledge base.
Data-driven, novel target candidates
"It was a real pleasure to work with Euretos and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions and swift responses. In addition, we found their platform very useful for getting an overview of the different targets and for general enquiries."
Tau Benned-Jensen, Senior Research Scientist, H. Lundbeck A/S.
Maximise target discovery potential
Empower your domain experts to evaluate target predictions
360 degree biological, functional and commercial target evaluation
Rapid onboarding
We support purchasing via scientist.com and science exchange!
Keep up with our latest news and events. Sign up for our newsletter.